论文部分内容阅读
日本《医学论坛报》第12卷第20期(1979年5月17日)第1页报道;据美国疾病控制中心(CDC)的报告,在美国胎儿成红细胞症的发病率自1968年Rh免疫球蛋白被发现以来,急速下降,1970年每出生一万婴儿,从40降至1975年的18。可是以后发病率未再下降。据1977年的最近资料来看,其发病率比以前每出生一万回升16。另一方面由溶血性疾病而引起的新生儿死亡(几乎全是由于Rh不适合者)从1968年每出生一万的2.72例,降至1976年每出生一万的0.74例。此死亡率下降与发病率不同,仍在明显继续下降中,死亡总数从1968年的941例降至1975年269例,1976年降至233例。又据康涅狄格州Rh登记处1977年度的报告,提出了很有希望的资料,约10年前在康涅狄克州,母亲自己是Rh阴性,但找出生产Rh阳性胎儿的母亲,给以Rh免疫球蛋白治疗,
Japan Medical Tribune Vol. 12, No. 20 (May 17, 1979) page 1; According to a report by the Centers for Disease Control and Prevention (CDC) in the United States, the incidence of fetal erythrocytic disease has been immunized since 1968 Globulin has been rapidly declining since its discovery, dropping from 40 to 18 in 1975 for every 10,000 babies born in 1970. However, the incidence did not decline afterwards. According to the most recent data from 1977, the incidence is 16% above the previous birth rate of 10,000. On the other hand, neonatal deaths caused by hemolytic diseases (almost exclusively due to Rh unavailability) decreased from 2.72 cases per 10,000 births in 1968 to 0.74 cases per 10,000 births in 1976. This decline in mortality and morbidity rates are still distinctly declining. The total number of deaths dropped from 941 in 1968 to 269 in 1975 and to 233 in 1976. According to the 1977 report of the Rh register in Connecticut, there was promising information about mother Rhodes in Connecticut 10 years ago, but the mother who produced Rh-positive fetuses was given Rh Immunoglobulin therapy,